Glatiramer acetate induced acute exacerbation of autoimmune hepatitis in a patient with multiple sclerosis

By Neumann Helmut   Csepregi Antal   Sailer Michael   Malfertheiner Peter  

Journal of Neurology, Vol. 254, Iss. 6, 2007-06 ,pp. : 816-817

Springer Publishing Company

Access to resources Recommend Favorite

Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo

By Weber Martin S.  

Brain, Vol. 127, Iss. 6, 2004-06 ,pp. : 1370-1378

Oxford University Press

Access to resources Recommend Favorite

Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy

By Ziemssen T.  

Brain, Vol. 125, Iss. 11, 2002-11 ,pp. : 2381-2391

Oxford University Press

Access to resources Recommend Favorite

Not such a bright idea: the UK risksharing scheme for beta interferon and glatiramer acetate in multiple sclerosis

By  

PRACTICAL NEUROLOGY, Vol. 3, Iss. 4, 2003-08 ,pp. : 194-195

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacodynamics of interferon beta in multiple sclerosis patients with or without serum neutralizing antibodies

By Scagnolari Carolina   Duda Petra   Bagnato Francesca   Vito Gabriella   Alberelli Alessia   Lavolpe Vito   Girardi Enrico   Durastanti Valentina   Trojano Maria   Kappos Ludwig   Antonelli Guido  

Journal of Neurology, Vol. 254, Iss. 5, 2007-05 ,pp. : 597-604

Springer Publishing Company

Access to resources Recommend Favorite